Skip to main content
. 2024 Apr 8;42(Suppl 1):S15–S27. doi: 10.1016/j.vaccine.2021.09.045

Table 4.

Regional Implementation of IA2030.

Commitment To achieve and sustain national and regional immunization goals & targets
Differentiated IA2030 Priorities According to country context (e.g., coverage & equity, hesitancy, integration of services, outbreaks, quality assured vaccine supply, sustainability)
Advocacy & Communications
Regional communication and advocacy platforms
Coordinated Operational Planning Monitoring & Evaluation Ownership & Accountability
Tools & Structures
  • Regional IA2030 Plans

  • 3–5 year regional operational plans

  • Regional Working Groups (e.g., strengthening of existing Gavi groups to include CSOs and coordinate support to non-Gavi countries)

  • Regional Interagency Coordinating Committees

  • IA2030 Impact Goal indicators, Global and Regional SP Objective indicators, and additional SP Objective indicators selected by regions tailored to needs and context

  • Scorecards with country and regional progress

  • Scorecards for partner/CSO progress

  • WHO-UNICEF Joint Reporting Form

  • WHO Immunization Information System

  • RITAGs

  • Regional Committees

  • Regional Working Groups

  • Other Regionally tailored structures (e.g., Regional Cooperation Organizations, Regional Accountability Councils)




Processes
  • RITAGs facilitated by development partners recommend key technical areas for focus across Member States

  • Coordination with UHC and PHC

  • Coordination with disease-specific initiatives

  • Monitor: compile country data to report on indicators

  • Evaluate: assess regional/national & partner/CSO progress using tailored indicator scorecards and identify potential root causes of success and failure

  • Act: Recommend actions for regional perfomance improvement and identify technical support needed for countries

  • Multi-year pledges from Partners/CSOs

  • Routine opportunities for consultative engagement organized by Working Groups